Business Description
ChromaDex Corp
NAICS : 325411
SIC : 2833
ISIN : US1710774076
Description
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.29 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -0.84 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.7 | |||||
| Beneish M-Score | -3.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.7 | |||||
| 3-Year EBITDA Growth Rate | 44.2 | |||||
| 3-Year EPS without NRI Growth Rate | 40.4 | |||||
| 3-Year Book Growth Rate | 12.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | 15.74 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.27 | |||||
| 9-Day RSI | 57.28 | |||||
| 14-Day RSI | 61.71 | |||||
| 6-1 Month Momentum % | 51.22 | |||||
| 12-1 Month Momentum % | 41.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | |||||
| Quick Ratio | 1.7 | |||||
| Cash Ratio | 1.32 | |||||
| Days Inventory | 146.28 | |||||
| Days Sales Outstanding | 30.27 | |||||
| Days Payable | 107.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.6 | |||||
| Shareholder Yield % | 0.23 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.76 | |||||
| Operating Margin % | -6.7 | |||||
| Net Margin % | -5.91 | |||||
| FCF Margin % | 8.34 | |||||
| ROE % | -17.69 | |||||
| ROA % | -9.16 | |||||
| ROIC % | -50.61 | |||||
| ROC (Joel Greenblatt) % | -56.99 | |||||
| ROCE % | -16.09 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 262 | |||||
| PS Ratio | 3.52 | |||||
| PB Ratio | 10.34 | |||||
| Price-to-Tangible-Book | 10.54 | |||||
| Price-to-Free-Cash-Flow | 42.26 | |||||
| Price-to-Operating-Cash-Flow | 41.37 | |||||
| EV-to-EBIT | -48.59 | |||||
| EV-to-EBITDA | -69.87 | |||||
| EV-to-Forward-EBITDA | 80.02 | |||||
| EV-to-Revenue | 3.26 | |||||
| EV-to-Forward-Revenue | 2.8 | |||||
| EV-to-FCF | 39.04 | |||||
| Price-to-Median-PS-Value | 0.55 | |||||
| Price-to-Net-Current-Asset-Value | 12.67 | |||||
| Price-to-Net-Cash | 393 | |||||
| Earnings Yield (Greenblatt) % | -2.06 | |||||
| FCF Yield % | 2.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ChromaDex Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 77.529 | ||
| EPS (TTM) (€) | -0.065 | ||
| Beta | 2.25 | ||
| Volatility % | 101.49 | ||
| 14-Day RSI | 61.71 | ||
| 14-Day ATR (€) | 0.203255 | ||
| 20-Day SMA (€) | 3.253 | ||
| 12-1 Month Momentum % | 41.98 | ||
| 52-Week Range (€) | 1.17 - 4.06 | ||
| Shares Outstanding (Mil) | 75.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ChromaDex Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ChromaDex Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
ChromaDex Corp Frequently Asked Questions
What is ChromaDex Corp(FRA:OCD1)'s stock price today?
The current price of FRA:OCD1 is €3.58. The 52 week high of FRA:OCD1 is €4.06 and 52 week low is €1.17.
When is next earnings date of ChromaDex Corp(FRA:OCD1)?
The next earnings date of ChromaDex Corp(FRA:OCD1) is 2024-05-10 Est..
Does ChromaDex Corp(FRA:OCD1) pay dividends? If so, how much?
ChromaDex Corp(FRA:OCD1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers